Editorial Expression of Concern: Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation Authors: Xueyan Cao, Yang Yang, Wei Zhou, Yue Wang, Xue Wang, Xianxiu Ge, Fei Wang, Fangfang Zhou, Xueting Deng, Lin Miao Published: 2026 Editorial Expression of Concern: BMC Cancer 23, 471 (2023) https://doi.org/10.1186/s12885-023-10954-8 The Editors would like to alert readers that concerns were raised regarding similar images in this article. Specifically, the Aprepitant 10 µM/12 h and Aprepitant 15 µM/0 h panels in Fig. 2B appear to overlap; and the Aprepitant 10 µM/12 h and Aprepitant 15 µM/0 h panels in Fig. 2B appear to overlap; and the Control/0 h and Aprepitant 10 µM /0 h panels in Fig. 3B appear to overlap the Control/0 h and Aprepitant 10 µM /0 h panels in Fig. 3B appear to overlap Readers are advised to interpret these results with caution. Authors Xueyan Cao, Yang Yang, Wei Zhou, Yue Wang, Xue Wang, Xianxiu Ge, Fei Wang, Fangfang Zhou, Xueting Deng and Lin Miao agree with this Editorial Express of Concern. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Xueyan Cao, Yang Yang and Wei Zhou contributed equally to the work and should be regarded as joint first authors. Contributor Information Xueting Deng, Email: xtdeng@njmu.edu.cn. Lin Miao, Email: linmiao@njmu.edu.cn.